Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm

Thrombosis is a more common occurrence in cancer patients compared to the general population and is one of the main causes of death in these patients. Low molecular weight heparin (LMWH) has been the recognized standard treatment for more than a decade, both in cancer-related thrombosis and in its p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojtukiewicz, Marek Z., Skalij, Piotr, Tokajuk, Piotr, Politynska, Barbara, Wojtukiewicz, Anna M., Tucker, Stephanie C., Honn, Kenneth V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281117/
https://www.ncbi.nlm.nih.gov/pubmed/32370207
http://dx.doi.org/10.3390/cancers12051144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281117/
https://www.ncbi.nlm.nih.gov/pubmed/32370207
http://dx.doi.org/10.3390/cancers12051144

Ejemplares similares